InSphero at the MPS World Summit 2026
Join us at the MPS World Summit 2026 in Washington, DC, where the global community comes together to advance microphysiological systems and human-relevant models.
We’re looking forward to engaging with the field around how technologies are evolving beyond standalone models toward more integrated, workflow-oriented approaches. We combine our 3D in vitro platforms with the expertise and infrastructure needed to support consistent, scalable, and decision-ready outcomes across the research pipeline.
Don't miss the opportunity to connect, exchange perspectives, and learn how these approaches can be applied within your own workflows.
Explore all our activities taking place during MPS Summit 2026 from Tuesday, May 26th to Friday, May 29th. See you soon!
Meet our Team at the MPS World Summit 2026


Jan Lichtenberg, PhD
Jan Lichtenberg, PhD
CEO and Co-Founder




Madhu Nag, PhD
Madhu Nag, PhD
Chief Scientific Officer




Anna Borgström, PhD
Anna Borgström, PhD
Deputy VP Liver Safety




Frauke Greve, PhD
Frauke Greve, PhD
Senior Product Manager




Olivier Frey, PhD
Olivier Frey, PhD
Vice President, Technologies and Platforms




Alexandra Title, PhD
Alexandra Title, PhD
Vice President, Islet Biology




Arnab China, PhD
Arnab China, PhD
Business Development Manager


Our Booth at the MPS World Summit 2026
Visit our booth #521 and discover our scalable, reliable and reproducible 3D in vitro technology designed to empower researchers and accelerate a new era of breakthrough therapies.
Educational Workshop at the MPS World Summit 2026
Adding Immune Competence to 3D In Vitro Disease Models: Finding the Sweet Spot Between Biological Complexity and Scalability Using Akura™ andGri3D® Technology
Date: Tuesday, May 26 2026 | 8:00 am - 11:30 am
Location: East Salon C


Anna Borgström, PhD
Anna Borgström, PhD
Deputy VP Liver Safety




Frauke Greve, PhD
Frauke Greve, PhD
Senior Product Manager


Breakfast Session at the MPS World Summit 2026
Inside the NAMs Workflow: Real-World Implementation Lessons in Pharma
Date: Wednesday, May 27 2026 | 7:30 am - 8:30 am
Location: Room 203A


Presentations, Talks & Panel Discussions at the MPS World Summit 2026
Scientific Talk: A 3D Imaging Toolbox for Islet Biology: Utilization of 3D High-Content Confocal Microscopy for the Characterization of Reaggregated Human Islets in Health and Disease
Session: Session 2.4 Modeling Human Disease: Metabolic Disorders
Date: Thursday, May 28 2026 | 11:30 pm - 1:00 pm


Alexandra Title, PhD
Alexandra Title, PhD
Vice President, Islet Biology


Workshop: Advancing Global Alignment on NAMs: Regulatory Roadmaps, Challenges and Opportunities
Role: Panelist
Date: Tuesday, May 26 2026 | 12:00 - 12:30pm
Virtual Control Groups: A Data-Driven Leap Forward in Nonclinical Study Deisgn
Role: Presenter
Date: Thursday, May 28 2026 | 8:00 am - 9:00 am
Session 4.4 Collaborative Validation Exercises: Developer-End User Dialogues
Role: Chair
Date: Thursday, May 28 2026 | 11:30 - 1:00 pm
Roundtable: Stakeholders Response to the Workshop: Advancing Global Alignment on NAMs: Regulatory Roadmaps, Challenges and Opportunities
Role: Speaker
Date: Thursday, May 28 2026 | 6:30 - 7:30 pm


Jan Lichtenberg, PhD
Jan Lichtenberg, PhD
CEO and Co-Founder


Roundtable: MPS and M-CELS: Now and in the Future
Role: Panelist
Date: Thursday, May 28 2026 | 6:30 pm - 7:30 pm
Session 4.5 Regulatory Acceptance Case Studies: Developer-Regulator Dialogues
Role: Chair
Date: Thursday, May 28 2026 |2:30 pm - 4:00 pm
Session 4.7 Scalability, Reproducibility, and Manufacturing-Readiness Strategies
Role: Chair
Date: Friday, May 29 2026 | 11:00 am - 1:00 pm


Madhu Nag, PhD
Madhu Nag, PhD
Chief Scientific Officer


Posters at the MPS World Summit 2026
"Scalable and reproducible 3D tumor spheroid platform for assessing therapeutic antibody penetration and efficacy"
Date: Wednesday, May 27 2026 | 10:00 - 11:30 am
Poster Number: 124
Abstract Number: 608


Madhu Nag, PhD
Madhu Nag, PhD
Chief Scientific Officer


"Leveraging low-input RNA-sequencing in human and animal liver microtissues to characterize mechanisms of drug-induced liver injury"
Date: Thursday, May 28 2026 | 4:00 - 5:30 pm
Poster Number: 125
Abstract Number: 225


Anna Borgström, PhD
Anna Borgström, PhD
Deputy VP Liver Safety


"Evaluation of drug-induced liver injury of trovafloxacin and chlorpromazine in human InSight™ 3D MASLD spheroid model"
Date: Thursday, May 28 2026 | 4:00 - 5:30 pm
Poster Number: 149
Abstract Number: 623


Frauke Greve, PhD
Frauke Greve, PhD
Senior Product Manager


"Multiparametric assays in 3D human liver microtissues: towards multiplexed in vitro NAMs for drug-induced liver injury (DILI) assessment"
Date: Thursday, May 28 2026 | 4:00 - 5:30 pm
Poster Number: 147
Abstract Number: 605


Olivier Frey, PhD
Olivier Frey, PhD
Vice President, Technologies and Platforms









